Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €0.57 EUR
Change Today +0.009 / 1.62%
Volume 2.5K
VCC On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:31 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Vijay B. Samant

Chief Executive Officer, President, Acting Chief Financial Officer and Director, Vical Incorporated
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 4 different industries.

See Board Relationships
62$1,464,005
As of Fiscal Year 2014

Background*

Mr. Vijay B. Samant has been the Chief Executive Officer of Vical Incorporated since 1990 and has been its President since November 2000. Mr. Samant joined Vical Inc. in November 2000 and has been its Acting Chief Financial Officer since April 12, 2013. He has over 23 years of U.S. and International Pharmaceuticals experience in the areas of Sales, Marketing, Operations and Business Development. Previously, Mr. Samant held various positions at Merck & Co., Inc. from ...

Read Full Background

Corporate Headquarters*

10390 Pacific Center Court
San Diego, California 92121

United States

Phone: 858-646-1100
Fax: 858-646-1150

Board Members Memberships*

2000-Present
Chief Executive Officer, President, Acting Chief Financial Officer and Director

Education*

MS
Columbia University
MBA
MIT Sloan School of Management
BS
University of Mumbai
BS
University Department of Chemical Technology India

Other Affiliations*

Annual Compensation*

Salary$557,000
Bonus$264,000
Total Annual Compensation$821,000

Stock Options*

Restricted Stock Awards$465,300
All Other Compensation$56,832
Exercisable Options1,971,625
Unexercisable Options737,375
Total Number of Options2,709,000

Total Compensation*

Total Annual Cash Compensation$877,832
Total Short Term Compensation$821,000
Other Long Term Compensation$522,132
Total Calculated Compensation$1,464,005
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCC:GR €0.57 EUR +0.009

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$964.7K
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
$375.0K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$543.6K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Kalevi Reijonen M.D.Chief Executive Officer and President
FIT Biotech Oy
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.